Heartflow (HTFL) Non-Current Debt (2024 - 2025)
Heartflow (HTFL) posted Non-Current Debt of $114.1 million for Q2 2025, down 16.38% on a QoQ basis from $136.4 million in Q4 2024.
Powered by 
Analysis
Heartflow (HTFL) Non-Current Debt (2024 - 2025) Analysis & Trends
Heartflow has reported Non-Current Debt for 2 years, with the latest figure at $114.1 million in Q2 2025.
- On a quarterly basis, Non-Current Debt changed N/A year-over-year to $114.1 million in Q2 2025; TTM through Jun 2025 was $114.1 million, a N/A change from a year earlier, with the FY2024 full-year figure at $136.4 million, changed N/A from the prior year.
- Non-Current Debt was $114.1 million for Q2 2025 at Heartflow, down from $136.4 million in the prior quarter.
- The five-year high for Non-Current Debt was $136.4 million in Q4 2024, with the low at $114.1 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn | 10.09 Bn |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn | 570.35 Mn |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | 793.70 Mn |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn | - |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - | 2.54 Bn |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn | 19.98 Mn |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn | 347.10 Mn |
| 10 | Prenetics Global | 357.49 Mn | 298.35 Mn | 30.20 Mn | - |